Entera Health News and Events
Learn more about what we’re up to and where we will be next!
November, 2019
ImmunoLin received import and distribution approval for Japan and Taiwan.
We are pleased to announce the addition of Japan and Taiwan to our SE. Asia markets. These new markets will further strengthen the international reach for our products and additional registrations are underway.
October 28, 2019
New Clinical Data for ImmunoLin Presented at FNCE, 2019.
New clinical data was presented at the 2019 Food and Nutrition Expo, in Philidelphia showing “oral supplementation with serum-derived bovine immunoglobulin protein isolate is associated with a reduction in the incidence of dietary endotoxemia.” This healthy human clinical trial will be followed by a larger placebo controlled study.
Key Study Findings
Regardless of dose, 45-days of ImmunoLin significantly reduced dietary endotoxemia in responder subjects.
Low dose administration of ImmunoLin were shown to improve dietary endotoxemia, 1g/d (p<0.05), 2g/d (p=0.118).
Trends toward reduced post-prandial cholesterol and PI cytokines reflect additional disease/metabolic improvements.
The trial shows good efficacy for lower doses of ImmunoLin related to dietary endotoxemia
The 2019 Food and Nutrition Expo (FNCE) was a great conference. A big thank you to Brian McFarlin, for presenting the New ImmunoLin data for Reduction in Dietary Endotoxemia.
October 17-19, 2019
Entera Health Exhibiting at Supply Side West, 2019
Stop by an visit us at SSW Booth #5281 to learn more about formulating products with ImmunoLin, a clinically researched, dairy-free IgG ingredient for dietary supplements. Be sure to request your free copy of “Life Begins in the Gut,” a New eBook by the Herbal Pharmacist, Dave Foreman. We look forward to seeing you at Supply Side!
L to R: Bobby Woods, Brian Kaufman, and Moises Contreras presented ImmunoLin, a diary-free IgG ingredient with a typical IgG content of 55%, to potential customers at Supply Side West (SSW) in October of 2019, in Las Vegas.
July 1, 2019
ImmunoLin, Serum-Derived Bovine Protein Isolate, receives approval for distribution in Vietnam, as a Health Supplement Ingredient.
Entera Health is excited to announce their new partnership with SAPHARCHAM, for the distribution of ImmunoLin into Vietnam. We are excited about the opportunity to bring new functional ingredients into SE. Asia to continue our mission of improving quality of life life for consumers worldwide. A big THANK YOU to SAPHARCHEM for hosting us to present ImmunoLin in Hanoi and Ho Chi Minh City. To learn more about SAPHARCHEM, please visit their website at http://sapharchem.com/en/trang-chu/.
